
    
      Patient inclusion in this study will be proposed 60 to 1-days period preceding the surgical
      procedure. The patient will be randomized in the crude PTFE or in the Propaten groups.
      Regarding the intervention, the technique used during the therapeutic procedure shall be left
      to the operator's discretion, except the type of the graft. Demographic, intraoperative and
      postoperative data will be collected prospectively. Patient will be assessed and followed up
      according a current care. The cost difference between both groups will be identified.
    
  